Abstract P6-10-02: Assessing biomarkers to inform treatment de-escalation: Mid-treatment biopsy cellularity predicts pCR in the I-SPY 2 TrialSara J. Venters, W. Fraser Symmans, Amy L. Delson et al.|Cancer Research|2020Cited by 7
Abstract P2-20-02: Site of recurrence after neoadjuvant therapy: Clues to biology and impact on endpointsChristina Yau, Laura J. Esserman, Angela DeMichele et al.|Cancer Research|2020Cited by 2